Patent · US Active

Antibody against the CSF-1R

US8604170B2 · kind B2 · utility

25Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2009
Grant dateDec 10, 2013
Priority date—
Expiry dateAug 13, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.